TW363051B - Substituted amidine derivatives and platelet aggregation inhibitor containing the same - Google Patents
Substituted amidine derivatives and platelet aggregation inhibitor containing the sameInfo
- Publication number
- TW363051B TW363051B TW085109661A TW85109661A TW363051B TW 363051 B TW363051 B TW 363051B TW 085109661 A TW085109661 A TW 085109661A TW 85109661 A TW85109661 A TW 85109661A TW 363051 B TW363051 B TW 363051B
- Authority
- TW
- Taiwan
- Prior art keywords
- platelet aggregation
- substituted amidine
- inhibitor containing
- aggregation inhibitor
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/20—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having nitrogen atoms of amidino groups acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treatment Of Sludge (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22309495 | 1995-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW363051B true TW363051B (en) | 1999-07-01 |
Family
ID=16792745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW085109661A TW363051B (en) | 1995-08-31 | 1996-08-07 | Substituted amidine derivatives and platelet aggregation inhibitor containing the same |
Country Status (11)
Country | Link |
---|---|
US (1) | US5719145A (zh) |
EP (1) | EP0760364B1 (zh) |
KR (1) | KR100225698B1 (zh) |
CN (1) | CN1062266C (zh) |
AT (1) | ATE194829T1 (zh) |
AU (1) | AU686515B2 (zh) |
DE (1) | DE69609382T2 (zh) |
DK (1) | DK0760364T3 (zh) |
ES (1) | ES2149411T3 (zh) |
NO (1) | NO305654B1 (zh) |
TW (1) | TW363051B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
TW363051B (en) * | 1995-08-31 | 1999-07-01 | Mitsui Toatsu Chemicals | Substituted amidine derivatives and platelet aggregation inhibitor containing the same |
US6828275B2 (en) | 1998-06-23 | 2004-12-07 | Bayer Aktiengesellschaft | Synergistic insecticide mixtures |
DE69828338T2 (de) * | 1997-07-18 | 2005-06-02 | Mitsui Chemicals, Inc. | Esterase und seine Verwendung zur Herstellung von optisch aktiven Chroman-Verbindungen |
TR200101744T2 (tr) | 1998-12-14 | 2001-12-21 | F. Hoffmann-La Roche Ag | Fenilglisin türevleri. |
CA2353151A1 (en) | 1998-12-16 | 2000-06-22 | Boehringer Ingelheim Pharma Kg | Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments |
EP1198231A1 (en) | 1999-07-21 | 2002-04-24 | American Home Products Corporation | Bicyclic antagonists selective for the(alpha)v(beta)3 integrin |
ES2610556T3 (es) | 2011-01-31 | 2017-04-28 | Council Of Scientific & Industrial Research | 1-(4-metilfenilmetil)-5-oxo-{N-[(3-t-butoxicarbonil-aminometil)]-piperidin-1-il}-pirrolidin-2-carboxamidas quirales como inhibidores de la activación y adhesión de plaquetas inducidas por colágeno |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029273A1 (en) * | 1993-06-09 | 1994-12-22 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
IL110172A (en) * | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicycle compounds and pharmaceuticals containing them |
US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
US5629321A (en) * | 1994-10-27 | 1997-05-13 | Mitsui Toatsu Chemicals, Inc. | Bicyclic compound and platelet aggregation inhibitor containing the same |
TW363051B (en) * | 1995-08-31 | 1999-07-01 | Mitsui Toatsu Chemicals | Substituted amidine derivatives and platelet aggregation inhibitor containing the same |
-
1996
- 1996-08-07 TW TW085109661A patent/TW363051B/zh active
- 1996-08-19 US US08/699,346 patent/US5719145A/en not_active Expired - Fee Related
- 1996-08-20 AU AU62172/96A patent/AU686515B2/en not_active Ceased
- 1996-08-21 NO NO963469A patent/NO305654B1/no unknown
- 1996-08-30 AT AT96113937T patent/ATE194829T1/de not_active IP Right Cessation
- 1996-08-30 DE DE69609382T patent/DE69609382T2/de not_active Expired - Fee Related
- 1996-08-30 EP EP96113937A patent/EP0760364B1/en not_active Expired - Lifetime
- 1996-08-30 DK DK96113937T patent/DK0760364T3/da active
- 1996-08-30 ES ES96113937T patent/ES2149411T3/es not_active Expired - Lifetime
- 1996-08-31 CN CN96113341A patent/CN1062266C/zh not_active Expired - Fee Related
- 1996-08-31 KR KR1019960037444A patent/KR100225698B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU6217296A (en) | 1997-05-08 |
EP0760364A3 (en) | 1998-07-29 |
NO963469L (no) | 1997-03-03 |
EP0760364A2 (en) | 1997-03-05 |
ES2149411T3 (es) | 2000-11-01 |
US5719145A (en) | 1998-02-17 |
CN1154962A (zh) | 1997-07-23 |
ATE194829T1 (de) | 2000-08-15 |
EP0760364B1 (en) | 2000-07-19 |
NO963469D0 (no) | 1996-08-21 |
AU686515B2 (en) | 1998-02-05 |
NO305654B1 (no) | 1999-07-05 |
KR100225698B1 (ko) | 1999-10-15 |
KR970010752A (ko) | 1997-03-27 |
DK0760364T3 (da) | 2000-10-09 |
CN1062266C (zh) | 2001-02-21 |
DE69609382T2 (de) | 2001-03-08 |
DE69609382D1 (de) | 2000-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0795548A4 (en) | CHINAZOZINE DERIVATIVES AND THEIR USE | |
NZ294933A (en) | Thienopyridine or thienopyrimidine derivatives, pharmaceutical compositions and use as anti-inflammatory agents | |
ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
AU1200695A (en) | 4,5-diaryloxazole derivatives | |
NO953844D0 (no) | 1-amidinofenyl-pyrrolidoner piperidinoner azetinoner som plateaggregeringshemmere | |
WO1999050255A3 (en) | Disubstituted pyrazolines and triazolines as factor xa inhibitors | |
CA2080705A1 (en) | Substituted pyrimidines | |
YU63699A (sh) | Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom | |
EP0889041A4 (en) | NEW IRIDOID DERIVATIVES AND NEOVASCULARIZATION INHIBITORS THAT CONTAIN THESE AS ACTIVE INGREDIENTS | |
CA2165995A1 (en) | Medicaments for the treatment of restenosis and arterial sclerosis | |
NO933524D0 (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
TW363051B (en) | Substituted amidine derivatives and platelet aggregation inhibitor containing the same | |
EP0593766A4 (en) | PYRIDONECARBOXYLIC ACID DERIVATIVE. | |
WO1993009791A3 (fr) | Utilisation de derives d'amphotericine b, comme inhibiteurs de proteases | |
EP0645382A4 (en) | CUMARIN DERIVATIVES AND THEIR USE. | |
NZ502133A (en) | Method of enhancing bioavailability of fexofenadine and its derivatives | |
BG105342A (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
EP0870502A3 (en) | Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis | |
CA2183234A1 (en) | Agent for prophylaxis and treatment of thromboxane a2-mediated diseases | |
WO1996028151A3 (en) | Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs | |
LT96094A (en) | The active ingredient of pharmaceutical composition for treating constipation | |
PT862433E (pt) | Composicao farmaceutica espumante topica para o tratamento de dermatoses induzidas por pityrosporum oval | |
ES2065855A1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
TW375525B (en) | Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives | |
EP0355409A3 (en) | Use of prolylendopeptidase inhibitors in the treatment of aids |